Geptanolimab Biosimilar (PDCD1 / PD-1 / CD279 Reference Antibody)
Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1) . Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer.
Product Specifications
Target
Geptanolimab Biosimilar (Anti-PDCD1 / PD-1 / CD279 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cancer Biology; Immunology & Inflammation; Cell Biology
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PA1922-Fluoro647 100 µg/Vial
Anti-MEK7/MAP2K7 Antibody Picoband® Fluoro647 Conjugated
Sign In for Pricing
View Details MBS2076012-01 0.1 mL
Cy3-Linked Polyclonal Antibody to Tight Junction Protein 2 (TJP2)
Sign In for Pricing
View Details